NIH awards Cleveland Clinic $7.2 million to study new diagnostic biomarker in MS

(Cleveland Clinic) The National Institutes of Health has awarded $7.2 million to a Cleveland Clinic-led research team to improve accuracy of multiple sclerosis diagnoses. The grant will support a multi-center study to evaluate whether a new biomarker, known as the central vein sign, can serve as a reliable diagnostic marker for MS.